WELLESLEY HILLS, Mass., April 08, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced ...

Climb Bio, Inc. stays a Buy on budoprutug pMN data; Phase 2 PrisMN readout 2H 2026 + SLE/ITP upside and 2028 cash runway.

Several Tisch programs, including the Hypercinema Lab, have made a deal with Runway AI. “We welcome the future,” he said.

Friends of Oceano Dunes issued a statement after a court ruled that the parks department violated the Endangered Species Act ...

Everything you need to know to stay up to date on the financial market. Information, trends and real-time charts on stock ...

Gov. Lou Leon Guerrero on Tuesday signed Sen. Telo Taitague’s bill into law, providing a pathway for foreign-trained doctors ...

Interparfums is under fresh scrutiny as analysts reaffirm a modeled fair value of US$111.20 per share, keeping the price target level while refining the underlying inputs. Supporters point to the ...

As I was preparing to write this column, I looked up the word "fail." To my surprise, the web version of Oxford Dictionary has a top 1,000-word feature. The word "fail" is firmly nested in its list of ...

The acquisition is expected to close during the first half of 2026 Aero Norway is based in Stavanger, Norway ITP Aero is an aerospace propulsion company ITP Aero, which is owned by Bain Capital, has ...

Researchers led by investigators at Mass General Brigham have published valuable information about a rare but serious complication of anti-cancer immunotherapy, providing the first large-scale ...

Current second-line treatments for immune thrombocytopenia (ITP) require long-term administration. Ianalumab, a monoclonal antibody targeting B cells, is being assessed as a short-course second-line ...